AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

FUROATE DE FLUTICASONE

8 registrations across 3 African markets— 7 active

Markets with FUROATE DE FLUTICASONE

Recent registrations

Brand / ProductMarketHolderStatusExpires
AVAMYS 27,5 ?G SUSPENSION POUR PULVERISATION NASALE FLACON DE 120 DOSES🇨🇮Côte d'IvoireGLAXOSMITHKLINE EXPORT LTDexpiredMar 2025
AVAMYS ™ 27,5µG SUS PULV NAS BTE (1 FLX120DOS)
suspension pulverisable
🇲🇬MadagascarGLAXOSMITHKLINE GROUP LTDactive
AVAMYS ™ 27,5µG SUS PULV NAS BTE (1 FLX120DOS)
suspension pulverisable
🇲🇬MadagascarGLAXOSMITHKLINE GROUP LTDactive
AVAMYS 27.5 µG/PULVERISATION
SUSPENSION POUR PULVERISATION NASALE
🇲🇦Moroccoactive
AVAMYS 27.5 µG/PULVERISATION
SUSPENSION POUR PULVERISATION NASALE
🇲🇦Moroccoactive
AVAMYS 27.5 µG/PULVERISATION
SUSPENSION POUR PULVERISATION NASALE
🇲🇦Moroccoactive
AVAMYS 27.5 µG/PULVERISATION
SUSPENSION POUR PULVERISATION NASALE
🇲🇦Moroccoactive
AVAMYS 27.5 µG/PULVERISATION
SUSPENSION POUR PULVERISATION NASALE
🇲🇦Moroccoactive

FUROATE DE FLUTICASONE in Africa — Regulatory Overview

FUROATE DE FLUTICASONE is registered across 3 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Madagascar, Côte d'Ivoire. AfricaRegulatory refreshes this data daily from official government sources.

Of the 8 registrations, 7 (88%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.